These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
501 related items for PubMed ID: 14732626
1. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists. Razmy A, Lang AE, Shapiro CM. Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626 [Abstract] [Full Text] [Related]
2. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U. Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269 [Abstract] [Full Text] [Related]
11. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J. JAMA; 2007 Mar; 287(4):455-63. PubMed ID: 11798367 [Abstract] [Full Text] [Related]
13. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Ondo WG, Perkins T, Swick T, Hull KL, Jimenez JE, Garris TS, Pardi D. Arch Neurol; 2008 Oct; 65(10):1337-40. PubMed ID: 18852348 [Abstract] [Full Text] [Related]
14. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease. Suzuki K, Miyamoto T, Miyamoto M, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K. J Neurol Sci; 2008 Aug 15; 271(1-2):47-52. PubMed ID: 18436241 [Abstract] [Full Text] [Related]
16. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Grosset K, Needleman F, Macphee G, Grosset D. Mov Disord; 2004 Nov 15; 19(11):1370-4. PubMed ID: 15389984 [Abstract] [Full Text] [Related]